Price T Rowe Associates Inc Igm Biosciences, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 4,014,259 shares of IGMS stock, worth $27.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,014,259

Previous 4,075,091 1.49%

Holding current value

$27.7 Million

Previous $28 Million 137.16%

% of portfolio

0.01%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.28 - $17.68 $382,024 - $1.08 Million	-60,832 Reduced 1.49%	4,014,259 $66.4 Million
Q2 2024 Aug 14, 2024	BUY	$6.51 - $11.47 $1.22 Million - $2.15 Million	187,068 Added 4.81%	4,075,091 $28 Million
Q1 2024 May 15, 2024	BUY	$8.68 - $17.36 $5.45 Million - $10.9 Million	628,001 Added 19.26%	3,888,023 $37.5 Million
Q4 2023 Feb 14, 2024	BUY	$3.94 - $8.79 $68,189 - $152,128	17,307 Added 0.53%	3,260,022 $27.1 Million
Q3 2023 Nov 14, 2023	BUY	$6.66 - $10.64 $78,887 - $126,030	11,845 Added 0.37%	3,242,715 $27.1 Million
Q2 2023 Aug 14, 2023	BUY	$8.86 - $14.0 $9.83 Million - $15.5 Million	1,109,995 Added 52.34%	3,230,870 $29.8 Million
Q1 2023 May 15, 2023	SELL	$13.74 - $25.76 $1.18 Million - $2.2 Million	-85,532 Reduced 3.88%	2,120,875 $29.1 Million
Q4 2022 Feb 14, 2023	SELL	$15.45 - $26.02 $175,496 - $295,561	-11,359 Reduced 0.51%	2,206,407 $37.5 Million
Q3 2022 Nov 14, 2022	SELL	$15.42 - $27.01 $6.25 Million - $10.9 Million	-405,107 Reduced 15.45%	2,217,766 $50.4 Million
Q2 2022 Aug 15, 2022	BUY	$13.27 - $25.5 $5 Million - $9.61 Million	376,832 Added 16.78%	2,622,873 $47.3 Million
Q1 2022 May 16, 2022	SELL	$13.42 - $29.73 $1.68 Million - $3.72 Million	-125,234 Reduced 5.28%	2,246,041 $60 Million
Q4 2021 Feb 14, 2022	BUY	$27.59 - $66.39 $381,045 - $916,912	13,811 Added 0.59%	2,371,275 $69.5 Million
Q3 2021 Nov 15, 2021	BUY	$65.76 - $90.65 $24.4 Million - $33.7 Million	371,393 Added 18.7%	2,357,464 $155 Million
Q2 2021 Aug 16, 2021	BUY	$57.98 - $96.6 $11 Million - $18.3 Million	189,760 Added 10.56%	1,986,071 $165 Million
Q1 2021 May 17, 2021	BUY	$71.56 - $121.23 $33.5 Million - $56.7 Million	467,527 Added 35.18%	1,796,311 $138 Million
Q4 2020 Feb 16, 2021	BUY	$47.41 - $115.03 $63 Million - $153 Million	1,328,784 New	1,328,784 $117 Million

Others Institutions Holding IGMS

# of Institutions

Shares Held

20.7M

Call Options Held

68K

Put Options Held

52.2K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $200M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Igm Biosciences, Inc. Transaction History